UPDATE OF THE TOPICAL TREATMENT OF PSORIASIS

被引:23
|
作者
Carrascosa, J. M. [1 ]
Vanaclocha, F. [2 ]
Borrego, L. [3 ]
Fernandez-Lopez, E. [4 ]
Fuertes, A. [5 ]
Rodriguez-Fernandez-Freire, L. [6 ]
Zulaica, A. [7 ]
Tuneu, A. [8 ]
Caballe, G. [9 ]
Colome, E. [9 ]
Bordas, X. [10 ]
Hernanz, J. M. [11 ]
Brufau, C. [12 ]
Herrera, E. [13 ]
机构
[1] Hosp Badalona Germans Trias & Pujol, Serv Dermatol, Barcelona 08916, Spain
[2] Hosp 12 Octubre, Serv Dermatol, Madrid, Spain
[3] Hosp Univ Insular Gran Canaria, Las Palmas Gran Canaria, Spain
[4] Hosp Univ Salamanca, Serv Dermatol, Salamanca, Spain
[5] Hosp Univ Dr Peset, Serv Dermatol, Valencia, Spain
[6] Hosp Univ Sevilla, Serv Dermatol, Seville, Spain
[7] Complejo Hosp Univ Vigo, Serv Dermatol, Vigo, Spain
[8] Hosp Donostia San Sebastian, San Sebastian, Spain
[9] LEO Pharma, Barcelona, Spain
[10] Ciutat Univ Bellvitge, Barcelona, Spain
[11] Hosp Infanta Leonor, Secc Dermatol, Madrid, Spain
[12] Hosp Gen Univ Reina Sofia, Secc Dermatol, Murcia, Spain
[13] Hosp Clin, Secc Dermatol, Malaga, Spain
来源
ACTAS DERMO-SIFILIOGRAFICAS | 2009年 / 100卷 / 03期
关键词
psoriasis; topical treatment; therapy;
D O I
10.1016/S0001-7310(09)70534-4
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Topical therapy continues to be one of the pillars of psoriasis management. Topical corticosteroids and vitamin D analogs are the drugs of choice during the induction phase, and vitamin D analogs continue to be drugs of choice for maintenance therapy. Tazarotene and dithranol are suitable options in patients with certain, specific characteristics. The calcineurin inhibitors can be considered to be second-line treatment for psoriasis of the face and flexures. The efficacy and safety of the fixed-dose combination of betamethasone and calcipotriol in the induction phase is greater than that of either drug alone. The combination of corticosteroids with salicylic acid achieves better results than corticosteroids in monotherapy. None of the drugs evaluated stands out over the others in all clinical situations, and their use must therefore be individualized in each patient and adjusted according to the course of the disease.
引用
收藏
页码:190 / 200
页数:11
相关论文
共 50 条
  • [41] TREATMENT OF PSORIASIS WITH TOPICAL ASCORBYL PALMITATE
    PERRICONE, NV
    CLINICAL RESEARCH, 1992, 40 (02): : A535 - A535
  • [42] Psoriasis: maximizing topical treatment concordance
    Gupta, Girish
    Bhattacharya, Susmita
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2007, 68 (05) : 263 - 266
  • [43] Topical calcipotriol in the treatment of intertriginous psoriasis
    Kienbaum, S
    Lehmann, P
    Ruzicka, T
    BRITISH JOURNAL OF DERMATOLOGY, 1996, 135 (04) : 647 - 650
  • [44] TOPICAL USE OF MECHLORETHAMINE IN TREATMENT OF PSORIASIS
    TAYLOR, JR
    HALPRIN, KM
    ARCHIVES OF DERMATOLOGY, 1972, 106 (03) : 362 - &
  • [45] New topical treatment for plaque psoriasis
    不详
    NURSE PRACTITIONER, 2019, 44 (08): : 56 - 56
  • [46] TREATMENT OF PSORIASIS WITH TOPICAL SELENIUM SULFIDE
    BORGLUND, E
    ENHAMRE, A
    BRITISH JOURNAL OF DERMATOLOGY, 1987, 117 (05) : 665 - 666
  • [47] TREATMENT OF PSORIASIS WITH TOPICAL ASCORBYL PALMITATE
    PERRICONE, NV
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1992, 98 (04) : 649 - 649
  • [48] Psoriasis: Update on Topical Therapy From the American Academy of Dermatology
    Shreiber, Alex M.
    Friery, Eileen
    AMERICAN FAMILY PHYSICIAN, 2022, 105 (05) : 558 - 560
  • [49] Topical corticosteroid therapy in psoriasis vulgaris: Update and new strategies
    Trozak, DJ
    CUTIS, 1999, 64 (05): : 315 - 318
  • [50] Topical Treatment of Psoriasis Vulgaris: The Swiss Treatment Pathway
    Maul, Julia-Tatjana
    Anzengruber, Florian
    Conrad, Curdin
    Cozzio, Antonio
    Hausermann, Peter
    Jalili, Ahmad
    Kolios, Antonios G. A.
    Laffitte, Emmanuel
    Lapointe, Anne-Karine
    Mainetti, Carlo
    Schlapbach, Christoph
    Trueeb, Ralph
    Yawalkar, Nikhil
    Dippel, Michaela
    Navarini, Alexander A.
    DERMATOLOGY, 2021, 237 (02) : 166 - 178